Insight into the Epigenetics of Kaposi's Sarcoma-Associated Herpesvirus.

DNA methylation Kaposi’s sarcoma-associated herpes virus epigenetics histone modification noncoding RNAs oncogenesis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 21 06 2023
revised: 25 07 2023
accepted: 28 07 2023
medline: 1 11 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

Epigenetic reprogramming represents a series of essential events during many cellular processes including oncogenesis. The genome of Kaposi's sarcoma-associated herpesvirus (KSHV), an oncogenic herpesvirus, is predetermined for a well-orchestrated epigenetic reprogramming once it enters into the host cell. The initial epigenetic reprogramming of the KSHV genome allows restricted expression of encoded genes and helps to hide from host immune recognition. Infection with KSHV is associated with Kaposi's sarcoma, multicentric Castleman's disease, KSHV inflammatory cytokine syndrome, and primary effusion lymphoma. The major epigenetic modifications associated with KSHV can be labeled under three broad categories: DNA methylation, histone modifications, and the role of noncoding RNAs. These epigenetic modifications significantly contribute toward the latent-lytic switch of the KSHV lifecycle. This review gives a brief account of the major epigenetic modifications affiliated with the KSHV genome in infected cells and their impact on pathogenesis.

Identifiants

pubmed: 37834404
pii: ijms241914955
doi: 10.3390/ijms241914955
pmc: PMC10573522
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Department of Biotechnology
ID : BT/RLF/Re-entry/23/2018

Références

Front Microbiol. 2017 Apr 20;8:613
pubmed: 28473805
Viruses. 2014 Dec 11;6(12):4961-98
pubmed: 25514370
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
J Virol. 2011 Jan;85(2):715-24
pubmed: 21068240
Cell. 2007 Feb 23;128(4):693-705
pubmed: 17320507
Cancers (Basel). 2015 Jan 14;7(1):112-42
pubmed: 25594667
Nat Rev Mol Cell Biol. 2023 Jun;24(6):430-447
pubmed: 36596869
PLoS Pathog. 2018 May 10;14(5):e1007062
pubmed: 29746587
Cell. 2009 Feb 20;136(4):642-55
pubmed: 19239886
PLoS Pathog. 2012;8(11):e1003007
pubmed: 23209403
PLoS Pathog. 2010 Jun 03;6(6):e1000935
pubmed: 20532208
Viruses. 2021 Jul 27;13(8):
pubmed: 34452335
Viruses. 2014 Nov 04;6(11):4212-26
pubmed: 25375885
Br J Cancer. 2003 Jan 13;88(1):109-14
pubmed: 12556968
RNA. 2006 May;12(5):733-50
pubmed: 16540699
Cell Rep. 2022 May 10;39(6):110788
pubmed: 35545047
Front Virol. 2021 Nov;1:
pubmed: 35141704
Cold Spring Harb Perspect Biol. 2016 Sep 01;8(9):
pubmed: 27194046
Curr Top Microbiol Immunol. 2011;349:197-244
pubmed: 20845110
Circulation. 2011 May 17;123(19):2145-56
pubmed: 21576679
Reprod Biol Endocrinol. 2020 Aug 13;18(1):84
pubmed: 32791974
Mol Cell. 2015 May 21;58(4):586-97
pubmed: 26000844
PLoS Pathog. 2018 Nov 1;14(11):e1007389
pubmed: 30383841
EMBO Mol Med. 2016 May 02;8(5):442-57
pubmed: 26992833
J Pathol. 2011 Jan;223(2):205-18
pubmed: 20957627
Trends Cancer. 2020 May;6(5):392-406
pubmed: 32348735
Trends Microbiol. 2017 Aug;25(8):648-661
pubmed: 28259385
Cancers (Basel). 2022 Nov 02;14(21):
pubmed: 36358814
Microbiol Mol Biol Rev. 2000 Jun;64(2):435-59
pubmed: 10839822
Viruses. 2018 Dec 24;11(1):
pubmed: 30586869
G3 (Bethesda). 2015 Jan 15;5(3):441-7
pubmed: 25591920
Int J Mol Sci. 2022 Jun 29;23(13):
pubmed: 35806208
Int J Mol Sci. 2019 Nov 08;20(22):
pubmed: 31717266
Int J Mol Sci. 2022 May 22;23(10):
pubmed: 35628612
Semin Immunopathol. 2020 Apr;42(2):143-157
pubmed: 32219477
Science. 2002 Nov 1;298(5595):1039-43
pubmed: 12351676
Nucleic Acids Res. 2013 Mar 1;41(5):2993-3009
pubmed: 23361465
Nature. 2011 Jul 13;475(7355):201-5
pubmed: 21753850
Mol Biotechnol. 2008 Mar;38(3):257-68
pubmed: 17999201
Viruses. 2014 Nov 04;6(11):4165-77
pubmed: 25375882
J Integr Bioinform. 2019 Jul 13;16(3):
pubmed: 31301674
Epigenetics. 2012 Oct;7(10):1098-108
pubmed: 22948226
Genes Dev. 2011 May 15;25(10):1010-22
pubmed: 21576262
Viruses. 2020 Apr 09;12(4):
pubmed: 32283586
J Virol. 2019 Feb 19;93(5):
pubmed: 30541837
Biochem Cell Biol. 2005 Jun;83(3):296-321
pubmed: 15959557
Natl Sci Rev. 2014 Jun;1(2):205-218
pubmed: 25512877
J Virol. 2019 Mar 5;93(6):
pubmed: 30567979
J Virol. 2017 Jan 31;91(4):
pubmed: 27928018
Cardiovasc Res. 2011 Jun 1;90(3):430-40
pubmed: 21558279
Viruses. 2015 Jan 12;7(1):72-109
pubmed: 25588053
J Virol. 2007 May;81(9):4722-31
pubmed: 17314169
PLoS Genet. 2014 May 08;10(5):e1004351
pubmed: 24809441
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4
pubmed: 7937876
PLoS Pathog. 2013;9(12):e1003813
pubmed: 24367262
Curr Top Microbiol Immunol. 2007;312:101-36
pubmed: 17089795
Cell Res. 2011 Mar;21(3):381-95
pubmed: 21321607
Cell Death Differ. 2001 Feb;8(2):113-26
pubmed: 11313713
Front Microbiol. 2020 Jul 31;11:1853
pubmed: 32849445
Mol Cell. 2006 Aug 4;23(3):289-96
pubmed: 16885019
Blood. 2001 May 15;97(10):3244-50
pubmed: 11342455
Viruses. 2020 Sep 17;12(9):
pubmed: 32957532
Future Virol. 2011 Apr;6(4):451-463
pubmed: 21799704
J Clin Invest. 2011 Mar;121(3):1141-53
pubmed: 21339646
PLoS Pathog. 2012;8(5):e1002680
pubmed: 22589717
J Biosci. 2020;45:
pubmed: 33184251
Front Microbiol. 2016 Aug 12;7:1149
pubmed: 27570517
Front Cell Infect Microbiol. 2021 Jul 09;11:666143
pubmed: 34307191
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14554-9
pubmed: 16983096
Virology. 1997 Sep 15;236(1):147-54
pubmed: 9299627
Future Microbiol. 2010 Sep;5(9):1349-65
pubmed: 20860481
Nat Rev Mol Cell Biol. 2012 Jun 22;13(7):436-47
pubmed: 22722606
Nat Rev Dis Primers. 2019 Jan 31;5(1):9
pubmed: 30705286
J Virol. 2013 May;87(10):5540-53
pubmed: 23468496
Biochim Biophys Acta. 2008 Mar;1782(3):127-50
pubmed: 18201576
J Cell Physiol. 2010 May;223(2):283-8
pubmed: 20112283
Cell Host Microbe. 2011 Nov 17;10(5):515-26
pubmed: 22100165
Nature. 1983 Jan 6;301(5895):89-92
pubmed: 6185846
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Epigenomics. 2009 Dec;1(2):239-59
pubmed: 20495664
Cancer Lett. 2010 Mar 28;289(2):140-50
pubmed: 19651473
J Virol. 2010 Jan;84(2):695-703
pubmed: 19889781
J Biomed Sci. 2020 Mar 7;27(1):41
pubmed: 32143650
Adv Virol. 2011;2011:
pubmed: 21625290
Nat Rev Drug Discov. 2013 Nov;12(11):847-65
pubmed: 24172333
Front Microbiol. 2019 Aug 07;10:1662
pubmed: 31616385
Microbiol Mol Biol Rev. 2003 Dec;67(4):657-85
pubmed: 14665679
Epigenetics. 2014 Jan;9(1):3-12
pubmed: 24739571
J Clin Invest. 2010 Apr;120(4):939-49
pubmed: 20364091
Oncogene. 2020 Jun;39(23):4603-4618
pubmed: 32393833
Virology. 2017 Dec;512:25-33
pubmed: 28898712
PLoS Pathog. 2020 Jan 10;16(1):e1008268
pubmed: 31923286
Clin Infect Dis. 2016 Mar 15;62(6):730-738
pubmed: 26658701
Nat Med. 2003 Mar;9(3):300-6
pubmed: 12592400
Development. 2009 Mar;136(6):879-89
pubmed: 19234061
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8737-E8745
pubmed: 30150410
Trends Genet. 2013 Nov;29(11):621-9
pubmed: 23870137
PLoS Pathog. 2020 Oct 15;16(10):e1009006
pubmed: 33057440
Front Microbiol. 2020 May 19;11:850
pubmed: 32508765
Int J Exp Pathol. 2001 Oct;82(5):269-86
pubmed: 11703537
Elife. 2021 Jul 19;10:
pubmed: 34279223
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5570-5
pubmed: 15800047
RNA Biol. 2013 Jun;10(6):925-33
pubmed: 23696037
Curr Probl Cancer. 2008 Sep-Oct;32(5):187-235
pubmed: 18926282
Br J Cancer. 2007 Jan 29;96(2):183-8
pubmed: 17179991
Int J Mol Sci. 2021 Dec 31;23(1):
pubmed: 35008848
Virology. 2011 Mar 15;411(2):325-43
pubmed: 21277611
Genes Chromosomes Cancer. 2010 Sep;49(9):775-90
pubmed: 20607704
Viruses. 2018 Feb 13;10(2):
pubmed: 29438328
J Virol. 2018 Jul 31;92(16):
pubmed: 29899086
Curr Protoc Microbiol. 2016 Feb 08;40:1E.10.1-1E.10.21
pubmed: 26855283
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893931
J Virol. 2006 Jan;80(2):697-709
pubmed: 16378973
Cell Mol Life Sci. 2009 Feb;66(4):596-612
pubmed: 18985277
Mol Ther. 2022 Jun 1;30(6):2153-2162
pubmed: 35143960
Genes Dev. 2004 Dec 15;18(24):3016-27
pubmed: 15574589
Cold Spring Harb Perspect Biol. 2016 Apr 01;8(4):a019521
pubmed: 27037415
Front Oncol. 2022 Mar 08;12:832047
pubmed: 35350569
Vet Pathol. 2014 Jul;51(4):759-74
pubmed: 24045890
J Virol. 2004 Jul;78(14):7299-310
pubmed: 15220403
Genes Dev. 2002 Aug 1;16(15):1977-89
pubmed: 12154127
Nature. 1997 Sep 18;389(6648):251-60
pubmed: 9305837
RNA Biol. 2018 Feb 1;15(2):186-193
pubmed: 29171328
RNA. 2004 Dec;10(12):1957-66
pubmed: 15525708
Open Biol. 2013 Oct 23;3(10):130144
pubmed: 24153005
Biochem Biophys Res Commun. 2010 Apr 9;394(3):482-7
pubmed: 20175997
PLoS Pathog. 2014 Jan;10(1):e1003847
pubmed: 24453964
Oncogene. 2002 Aug 12;21(35):5427-40
pubmed: 12154405
PLoS Pathog. 2016 Sep 08;12(9):e1005878
pubmed: 27606464
Biochim Biophys Acta. 2009 Jan;1789(1):45-57
pubmed: 18603028
Viruses. 2015 Jan 14;7(1):116-53
pubmed: 25594835
Clin Genet. 2012 Apr;81(4):303-11
pubmed: 22082348
Front Genet. 2015 Jan 26;6:2
pubmed: 25674102
Future Microbiol. 2011 Dec;6(12):1399-413
pubmed: 22122438
Chem Rev. 2015 Mar 25;115(6):2255-73
pubmed: 25495456
PLoS Pathog. 2010 Jul 22;6(7):e1001013
pubmed: 20661424
Viruses. 2013 May 23;5(5):1346-73
pubmed: 23698402
Cancer Res. 2000 Sep 1;60(17):4873-80
pubmed: 10987301
Nat Rev Cancer. 2010 Oct;10(10):707-19
pubmed: 20865011
Mol Cell. 2022 Jan 6;82(1):30-43
pubmed: 34942118
Exp Ther Med. 2020 Oct;20(4):2923-2940
pubmed: 32855658
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118
pubmed: 33353982
Nucleic Acids Res. 1983 Oct 11;11(19):6883-94
pubmed: 6314264
Blood. 2008 May 1;111(9):4731-40
pubmed: 18199825
Genetics. 2013 Mar;193(3):651-69
pubmed: 23463798
Am J Pathol. 2016 Jul;186(7):1724-35
pubmed: 27338107
Expert Rev Proteomics. 2005 Oct;2(5):719-29
pubmed: 16209651
FEBS Lett. 2018 Jun;592(12):1980-1996
pubmed: 29683487
J Virol. 2003 Jun;77(11):6188-96
pubmed: 12743275
Int J Mol Sci. 2013 Jul 31;14(8):16010-39
pubmed: 23912238
Cell Cycle. 2014;13(5):845-58
pubmed: 24419204
J Clin Med. 2017 Nov 29;6(12):
pubmed: 29186062

Auteurs

Anusha Srivastava (A)

Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.

Ankit Srivastava (A)

Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.

Rajnish Kumar Singh (RK)

Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.
Faculty of Medical Sciences, Charotar University of Science and Technology, Changa 388421, Gujarat, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH